As Pandemic Continues To Rage, Biotech Firms Begin Kicking Off Clinical Trials

The New York Times (4/8, Sheikh, Thomas) reports, “Just three months after the start of the coronavirus pandemic, several biotech companies are beginning trials of promising vaccines and treatments.” On Wednesday, Novavax, “a Maryland-based biotech compan...